SR One Capital Management, LP
15 holdingsFiling period: 2026-06-30Current AUM: $954.8Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | MANE | Veradermics, Inc. | 2.40M | $295.3M | $335.5M | 35.14% | -- | 2026-06-30 |
| 2 | ZBIO | Zenas BioPharma, Inc | 5.04M | $127.9M | $143.0M | 14.98% | -- | 2026-06-30 |
| 3 | — | CRISPR Therapeutics AG | 2.04M | $111.2M | $111.2M | 11.65% | -- | 2026-06-30 |
| 4 | AVLN | Avalyn Pharma, Inc | 3.31M | $108.9M | $84.8M | 8.88% | -- | 2026-06-30 |
| 5 | DSGN | Design Therapeutics, Inc. | 6.53M | $94.4M | $69.7M | 7.30% | -- | 2026-06-30 |
| 6 | ODTX | Odyssey Therapeutics, Inc. | 3.79M | $71.0M | $74.2M | 7.77% | -- | 2026-06-30 |
| 7 | ALMS | Alumis Inc. | 1.96M | $55.2M | $13.2M | 1.38% | -- | 2026-06-30 |
| 8 | ORIC | ORIC Pharmaceuticals, Inc. | 4.62M | $50.0M | $42.6M | 4.47% | +100.5K | 2026-06-30 |
| 9 | MLYS | Mineralys Therapeutics Inc. | 1.56M | $42.2M | $28.4M | 2.98% | -- | 2026-06-30 |
| 10 | SPRY | ARS Pharmaceuticals, Inc. | 4.01M | $32.1M | $13.6M | 1.42% | -- | 2026-06-30 |
| 11 | MOBI | Mobia Medical, Inc | 1.99M | $26.6M | $21.0M | 2.20% | -- | 2026-06-30 |
| 12 | NKTX | Nkarta, Inc. | 3.33M | $9.4M | $5.2M | 0.54% | -- | 2026-06-30 |
| 13 | — | Oculis Holding AG | 641.0K | $8.9M | $8.9M | 0.93% | -- | 2026-06-30 |
| 14 | RARE | Ultragenyx Pharmaceutical Inc. | 137.8K | $4.6M | $2.2M | 0.23% | -- | 2026-06-30 |
| 15 | — | enGene Holdings Inc. | 747.8K | $1.3M | $1.3M | 0.14% | -- | 2026-06-30 |
← Scroll →